圍術(shù)期靜脈輸注利多卡因?qū)π乜剖中g(shù)病人術(shù)后鎮(zhèn)痛效果的研究
[Abstract]:Study Background: Pain is an unpleasant feeling or emotional experience caused by tissue damage or potential tissue damage. The post-operative pain is an acute pain that occurs immediately after the procedure, which is clinically common and requires a timely treatment. In various types of surgery, the pain in the thoracic surgery is particularly acute, which has also become the main cause of the patient's fear of the thoracic surgery. I. The primary cause of post-operative pain is the trauma of intercostal nerves, muscle ligaments, and the trauma of the incision and the stimulation of the body. and the like, and the pain after the operation can directly influence the amplitude of the breathing motion and the process of the cough and the sputum, so that the secretion of the secretion in the respiratory tract can be retained, and then the lung can not be caused, the pleural effusion, the chest infection and the like can be caused, and the severe person can even cause the respiratory failure and the death Therefore, the timely and effective and reasonable analgesia can not only improve the respiratory function of the patients after operation, reduce the occurrence of postoperative complications, but also promote the recovery of the patient from the operation of the operation as soon as possible. Complex. The method of self-controlled analgesia (PCIA), which is currently used in clinical use, is one of the most effective and effective methods for postoperative analgesia in patients with thoracic surgery, but a single analgesic method often does not achieve the desired analgesic effect. As a result, the use of two or more analgesic methods for compound analgesia is increasingly becoming the general trend Potential. Epidural pain is a well-recognized standard for postoperative analgesia, but its complications, contraindications and adverse reactions limit the clinical application of this method to a certain extent. In this paper, the analgesic effect of the postoperative patient-controlled analgesia (PCIA) in the patients with thoracic surgery was observed after the perioperative and intravenous injection of lidocaine in the patients with thoracic surgery. Objective: To observe the analgesic effect of the patient-controlled analgesia (PCIA) and the postoperative rehabilitation of the patients after the intravenous infusion of lidocaine in the perioperative period of the patients with thoracic surgery. Methods: 120 patients who underwent thoracic surgery under general anesthesia were randomly divided into two groups (n = 60). A group (group A of lidocaine) was used as lidocaine, fentanyl, sufentanil and zizine. in group B (control group), remifentanil, sufentanil, zizine, The postoperative self-controlled intravenous analgesia was performed in both groups of patients in the group A and B. PCIA). All patients have a unified surgical method and a method of anesthesia, both of which are all used Intravenous anesthesia. Intraoperative and postoperative analgesia The analgesic was performed by the method of intravenous patient self-control and analgesia (PCIA), and the drug was sufentanil 100 ug, desmaxin 150mg, and ramosetron 0. 6mg, and diluted with normal saline. 100ml. Then, another anesthesiologist who did not know the grouping condition used the visual simulation scoring method (VAS) to evaluate the analgesic effect (including the VAS score at rest and cough) for 1h, 4h, 8h, 24h, 48h and 72h after the operation of the patient, and record the number of pressing times and adverse reactions of the PCIA. Postoperative complications, vital signs, sedation, nausea, and vomiting Score and The results were as follows: (1) VAS score at rest, 1 h, 4 h, and 8 h at rest, and there was a significant difference between group A and group B (P <0.05), and 24 hours after operation. The scores of analgesia in group A and group B were no significant difference (P0.05). (2) VAS score at the time of cough, the analgesic score of group A was significantly different from group B, and there was a significant difference between group B and group B (P <0.05). The analgesic scores of group A and group B were no significant difference after operation for 48h and 72h, and there was no statistics. The clinical significance (P 0.05). 2. The comparison of the additional analgesic drugs: the time interval between the two groups was compared with each other, and the number of pressing times for 1h, 4h, 8h and 24h after operation was significantly higher than that in group A (P0.05). The study significance (P0.05). The number of pressing times of 48h and 72h after operation was compared, and the group A and group B did not Significant difference (P0.05). 3. Comparison of postoperative cough and expectoration ability: A group of patients can better cooperate with cough and expectoration, and the respiratory tract The discharge of internal secretion, group A was better than that of group B. The results showed that the sedation score of group B was significantly lower in group A than in group A. The sedative effect of group B was poor in group B, and the rest of the time was the same. There was no significant difference in the sedation score (P0.05). The postoperative pain was less and the degree of satisfaction of group A was better than that of group B. Conclusion: After the intravenous infusion of lidocaine in the perioperative period of the thoracic surgery, the analgesic effect of the post-operative PCIA can be enhanced, the postoperative pain can be relieved, and the occurrence of postoperative complications is also reduced. and no severe lidocaine was observed.
【學(xué)位授予單位】:吉林大學(xué)
【學(xué)位級別】:碩士
【學(xué)位授予年份】:2014
【分類號】:R655;R614
【參考文獻(xiàn)】
相關(guān)期刊論文 前10條
1 陳永東,邵中夫,趙光日,王遠(yuǎn)東;肋間神經(jīng)冷凍止痛在預(yù)防開胸術(shù)后切口疼痛的臨床研究[J];國際醫(yī)藥衛(wèi)生導(dǎo)報;2005年04期
2 滕金亮;術(shù)后鎮(zhèn)痛對呼吸功能的影響[J];國外醫(yī)學(xué).麻醉學(xué)與復(fù)蘇分冊;2000年03期
3 楊金良;黃剛;張萌;任迎春;張力克;曹利娟;張進(jìn)華;;克澤普注射液肋間神經(jīng)阻滯鎮(zhèn)痛在剖胸術(shù)后患者的應(yīng)用[J];河北醫(yī)藥;2007年03期
4 晁葳,梁伍,付明鶴,郭桂珍;術(shù)后鎮(zhèn)痛副作用的臨床觀察[J];河南外科學(xué)雜志;2004年01期
5 高玉華;閔紅星;施偉忠;;肋間神經(jīng)阻滯聯(lián)合靜脈PCA在開胸術(shù)后鎮(zhèn)痛的應(yīng)用[J];寧夏醫(yī)學(xué)雜志;2009年05期
6 苗桂萍;疼痛控制及護(hù)理的新進(jìn)展[J];中國實用護(hù)理雜志;2001年02期
7 羅興均;簡道林;;靜脈注射利多卡因鎮(zhèn)痛的作用機(jī)制[J];實用醫(yī)學(xué)雜志;2010年15期
8 鄒毅清;聶海貴;魏斌;曾淑珍;李小寶;楊志星;;靜脈輸注利多卡因?qū)Ω共看笫中g(shù)炎癥反應(yīng)的影響[J];現(xiàn)代中西醫(yī)結(jié)合雜志;2009年27期
9 裴皓;羅愛林;;舒芬太尼藥理作用與臨床應(yīng)用[J];醫(yī)藥導(dǎo)報;2009年11期
10 周攀科;蘭志勛;;地佐辛用于術(shù)后鎮(zhèn)痛的研究進(jìn)展[J];實用醫(yī)院臨床雜志;2011年06期
本文編號:2421662
本文鏈接:http://sikaile.net/yixuelunwen/mazuiyixuelunwen/2421662.html